Could a popular weight-loss drug fix PCOS-related period problems?

NCT ID NCT07326111

Recruiting now Disease control Sponsor: University of Bonn Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 20 times

Summary

This study tests whether tirzepatide, a drug already approved for diabetes and obesity, can improve irregular periods in overweight women with PCOS. About 198 women will receive either tirzepatide or a placebo for 72 weeks. The goal is to see if the drug helps restore normal menstrual cycles and ovulation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY; OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospital BG Bergmannsheil Bochum General internal medicine, endocrinology and diabetology, gastroenterology and hepatology
ENROLLING_BY_INVITATION

Bochum, 44789, Germany
University Hospital Bonn Division of Endocrinology, Diabetes and Metabolism
RECRUITING

Bonn, 53127, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

OBESITY; OVERWEIGHT POLYCYSTIC OVARY SYNDROME (PCOS)